No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
IMNM Immunome
- 10.970
- -0.110-0.99%
Close Dec 20 16:00 ET
- 10.970
- 0.0000.00%
Post 20:01 ET
684.71MMarket Cap-1.38P/E (TTM)
11.500High10.820Low1.45MVolume10.940Open11.080Pre Close16.07MTurnover3.21%Turnover RatioLossP/E (Static)62.42MShares30.95852wk High3.19P/B496.31MFloat Cap8.97052wk Low--Dividend TTM45.24MShs Float63.780Historical High--Div YieldTTM6.14%Amplitude2.090Historical Low11.053Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
Immunome President Acquires 24% More Stock
Immunome Insider Bought Shares Worth $962,181, According to a Recent SEC Filing
Immunome CEO Clay Siegall Acquires $962,181 in Company Stock
Heat List
US
Overall
Symbol
Price
% Chg
No Data